Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Disease area: Pulmonary vascular diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Dermech, S. Souilah, F.Z. Ellalia, A. Fissah, S. Taright, R. Amrane (Alger, Algeria). Venous thromboembolic disease and bronchial cancer. Eur Respir J 2012; 40: Suppl. 56, 598

Member's Comments

No comment yet.

Related content which might interest you: Risk of venous thromboembolism in lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Venous thromboembolism in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Venous thromboembolism and pulmonary cancer: A ten years series Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Venous thromboembolism in lung cancer with clinical analysis of 89 cases Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018 The incidence of serious venous thromboembolic events in 1157 lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 COPD and thrombosis Source: Eur Respir Mon 2013; 59: 206-216 Year: 2013 Pulmonary thromboembolism in patients with fibrotic lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 356s Year: 2006 Venous thromboembolic disease in patients with small cell lung cancer: incidence and clinicopathological risk factors Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Venous thromboemboli and exacerbations of COPD Source: Eur Respir J 2010; 35: 1243-1248 Year: 2010 Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Treatment and prevention of cancer-associated venous thromboembolism Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017 Year: 2017 Clinical implications of incidental venous thromboembolism in cancer patients Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019 Year: 2020